NCT00123864
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
Clinical trial condition
Nasopharyngeal Neoplasms
Explore clinical trials studying Nasopharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.
25 public trials
3 recruiting studies
Nasopharyngeal Neoplasms trial results
Completed
Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
NCT00436800
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- Sanofi-Aventis Administrative Office Hong Kong
NCT00078494
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- National Institutes of Health Clinical Center (CC) Bethesda, Maryland, United States
Active, Not Recruiting
Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT05807880
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Active, Not Recruiting
GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03840421
- Conditions
- Carcinoma, Head and Neck Neoplasm, Head and Neck Neoplasms, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China